 |
The Journal of Neuroscience, November 14, 2007, 27(46):12484-12488; doi:10.1523/JNEUROSCI.3133-07.2007
Previous Article | Next Article 
Brief Communications
Cocaine-Conditioned Place Preference by Dopamine-Deficient Mice Is Mediated by Serotonin
Thomas S. Hnasko,1 *
Bethany N. Sotak,2 * and
Richard D. Palmiter2
1Graduate Program in Neurobiology and Behavior and 2Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, Washington 98195
Correspondence should be addressed to Richard D. Palmiter, Howard Hughes Medical Institute, Box 357370, University of Washington, Seattle, WA 98195. Email: palmiter{at}u.washington.edu
Rodents learn to associate the rewarding effects of drugs with the environment in which they are encountered and, subsequently, will display a conditioned place preference (CPP) for that environment. Cocaine-induced CPP is generally thought to be mediated through inhibition of the dopamine transporter and the consequent increase in extracellular dopamine. However, here we report that dopamine-deficient (DD) mice formed a CPP for cocaine that was not blocked by a dopamine D1-receptor antagonist. Fluoxetine, a serotonin transporter (SERT) inhibitor, produced CPP in DD, but not control mice, suggesting that serotonin mediates cocaine CPP in DD mice. Inhibition of dopamine neuron firing by pretreatment with quinpirole, a dopamine D2-receptor agonist, blocked both cocaine- and fluoxetine-induced CPP in DD mice. These findings are consistent with the hypothesis that, in the absence of dopamine, cocaine-mediated SERT blockade activates dopamine neurons, which then release some other neurotransmitter that contributes to cocaine reward in DD mice.
Key words: cocaine; conditioned place preference; dopamine; dopamine-deficient; dopamine transporter; serotonin transporter
Received July 10, 2007;
revised Sept. 11, 2007;
accepted Oct. 2, 2007.
Correspondence should be addressed to Richard D. Palmiter, Howard Hughes Medical Institute, Box 357370, University of Washington, Seattle, WA 98195. Email: palmiter{at}u.washington.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2007 27: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
B. B. Land, M. R. Bruchas, S. Schattauer, W. J. Giardino, M. Aita, D. Messinger, T. S. Hnasko, R. D. Palmiter, and C. Chavkin
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
PNAS,
November 10, 2009;
106(45):
19168 - 19173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Darvas and R. D. Palmiter
Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors
PNAS,
August 25, 2009;
106(34):
14664 - 14669.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Nicholson, R. L. Balster, K. Golembiowska, M. Kowalska, J. P. Tizzano, P. Skolnick, and A. S. Basile
Preclinical Evaluation of the Abuse Potential of the Analgesic Bicifadine
J. Pharmacol. Exp. Ther.,
July 1, 2009;
330(1):
236 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-C. Tsai, F. Zhang, A. Adamantidis, G. D. Stuber, A. Bonci, L. de Lecea, and K. Deisseroth
Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning
Science,
May 22, 2009;
324(5930):
1080 - 1084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Zweifel, J. G. Parker, C. J. Lobb, A. Rainwater, V. Z. Wall, J. P. Fadok, M. Darvas, M. J. Kim, S. J. Y. Mizumori, C. A. Paladini, et al.
From the Cover: Feature Article: Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior
PNAS,
May 5, 2009;
106(18):
7281 - 7288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Caron and R. M. Wightman
"To learn, you must pay attention." Molecular insights into teachers' wisdom
PNAS,
May 5, 2009;
106(18):
7267 - 7268.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Figlewicz and S. C. Benoit
Insulin, leptin, and food reward: update 2008
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2009;
296(1):
R9 - R19.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|